Read more in the study ‘The impact of Covid-19 on access to Parkinson’s disease medication’.
Has Covid-19 impacted access to Parkinson’s medication?
News
Author: Simge Eva DoganPublished: 17 September 2020
Prep:
Cook:
Serves:
New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease.
The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors.
The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication.
“Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”
For more information on Parkinson’s and Covid-19 please visit the EPDA website.
Read more:
Brazilian dance could improve mobility in people with Parkinson’s, study finds
#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’
Last Month
Next Month
Share this story
Related articles
Global update
Parkinson’s in the news: June
We round up the top Parkinson’s news stories from around the globe
READ MORE
Resources & Tools
Brush up on your Parkinson’s terminology with this free glossary
Free downloadable and printable A-Z of Parkinson’s disease
READ MORE
Health & Fitness
The 8th Parkinson’s ‘Olympics’ targets key exercise habits
It’s the exercise that counts at the Parkinsoniada games
READ MORE
Comments